SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention after a sharp, high-volume breakout without a confirmed company announcement. Traders attribute the move to possible institutional buying and short covering, while speculation about Anktiva-related regulatory news competes with caution that no new catalyst has been verified.

Select Sector SPDR Trust (The) - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

XLU is drawing attention for a tentative rebound after a steep sector selloff, with traders highlighting unusually heavy call-option activity and signs of firmer bond markets. Bulls see a potential bottom, while others remain cautious because utilities are sensitive to Treasury yields and the rate outlook is unsettled.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Sam Altmans statement that OpenAI remains a close Cerebras partner with deep engagement has sparked a bullish rebound narrative, with traders arguing it counters concerns about OpenAI using Nvidia chips for a newer inference tier. Skeptics still point to upcoming insider share unlocks and selling pressure as risks.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is drawing attention after a strong quarterly report and higher adjusted EBITDA outlook, alongside a DefenCath supply agreement with DaVita. Traders remain divided: bulls see commercial momentum, while skeptics question the near-term outlook amid lower post-TDAPA reimbursement and uncertainty about future adoption and coverage.

Daily surprises, near and far. Your source for travel inspiration and more. Travel moves you!

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Court approval of the settlement cleared a major legal obstacle to Paramounts acquisition of Warner Bros. Discovery, with closing scheduled for October 6. Traders are focused on WBDs narrow gap to the fixed cash buyout value and the remaining per-day fee, though some still note legal challenges and closing uncertainty.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON is gaining attention after revising its Synaptics acquisition to an all-cash deal, easing concerns about share dilution and with the company expecting earlier earnings accretion. Traders broadly welcomed the change, though some remain wary of added debt and integration risks.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

DECK is under pressure amid broad weakness in footwear and retail stocks, with concerns about softer consumer demand and worries that it could face challenges similar to Nike; a BMO Underperform rating has added to the bearish discussion. Many traders see the selloff as excessive given Deckers cash position, buybacks and HOKA/UGG business, and are looking for a bottom, while others warn the sector downturn may continue.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

ENPH is drawing attention for a volatile technical rebound after an extended decline, with bullish traders calling for a breakout or short squeeze while bears warn the move may fade. The debate centers on whether the stock is oversold or still pressured by high rates and weak residential-solar demand; some traders also point to Enphases potential AI data-center transformer business as a longer-term catalyst.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA approval of daraxonrasib (RASONQUE) for metastatic pancreatic cancer, supported by pivotal survival results, remains the main catalyst. Traders are bullish on its commercial potential but debate the companys valuation and the drugs price, while emerging resistance concerns add uncertainty.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figmas sharp swings are fueling debate over employee and insider share sales, high stock-based compensation, and whether AI will disrupt its design-software business or become a revenue driver. Traders also point to declining short interest and software-sector rebounds as potential support, though views remain divided on whether the stock can sustain a recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
